News

MannKind, a biopharmaceutical company, has submitted a new drug application to the FDA requesting approval of Afresa inhalation powder and the Afresa inhaler for the treatment of adults

Under terms of the agreement, Merck, whose researchers discovered the candidate, has granted Medicines for Malaria Venture (MMV) an exclusive, royalty-free license to pursue development of the investigational

The funding will support a Phase I/IIa clinical study to test the safety and the efficacy of the company’s product, BKT140 as a therapeutic treatment for myeloma and

The small business technology transfer (STTR) award will be used to support a research collaboration between Numerate and the laboratory of Chaitan Khosla, the Wells Rauser and Harold

Cardinal Health has opened a new facility in Omaha, Nebraska that manufactures radiopharmaceuticals, giving local physicians new tools that aid in the early diagnosis and treatment of disease.

According to the agreement, Vicor’s PD2i cardiac analyzer will be used by University of Rochester personnel to identify which of the 651 congestive heart failure patients who participated

Foundation Capital led the round and was joined by Lanza techVentures, both existing investors. Guido Lanza, president and CEO of Numerate, said: “This investment will help support our

Spectrum Pharmaceuticals, a biopharmaceutical company, has announced the closing of the transaction whereby Spectrum acquired 100% control of RIT Oncology to commercialize Zevalin in the US. In connection

Healthpoint, an affiliate of DFB Pharmaceuticals, a specialty pharmaceutical company, has initiated a Phase II clinical trial investigating the efficacy of HP802-247 in venous leg ulcers. HP802-247 is